Oramed Pharmaceuticals Stock Forecast

Sell candidate since Jul 31, 2026

The Oramed Pharmaceuticals Inc. stock price fell by -1.21% on the last day (Friday, 31st Jul 2026) from $4.12 to $4.07. During the last trading day the stock fluctuated 4.64% from a day low at $3.94 to a day high of $4.13. The price has risen in 5 of the last 10 days and is up by 0.99% over the past 2 weeks. Volume has increased on the last day by 58 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 207 thousand shares were bought and sold for approximately $842.73 thousand.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Oramed Pharmaceuticals Inc. stock with a 90% probability to be traded between $3.63 and $5.03 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

ORMP Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, July 13, 2026, and so far it has risen 2.91%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Oramed Pharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.10 and $4.17. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Oramed Pharmaceuticals Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Oramed Pharmaceuticals Inc. stock

Oramed Pharmaceuticals Inc. finds support from accumulated volume at $4.04 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.183 between high and low, or 4.64%. For the last week, the stock has had daily average volatility of 4.13%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ORMP) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Oramed Pharmaceuticals Inc. to open at $4.05, and during the day (based on 14 day Average True Range), to move between $3.97 and $4.17, which gives a possible trading interval of +/-$0.210 (+/-5.30%) up or down from last closing price. If Oramed Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 5.30% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.04 (0.74%) than the resistance at $4.61 (13.27%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Oramed Pharmaceuticals Inc. stock A Buy?

Oramed Pharmaceuticals Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -4.444 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $4.05 ( 0.598%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk